leadf
logo-loader
viewMaxCyte Inc

MaxCyte inks licensing deal with cutting-edge US cancer drug developer

Its technology will be used to deliver gene editing machinery into blood stem cells

MaxCyte Inc -

MaxCyte Inc (LON:MXCT) said American cancer research firm Vor Biopharma will use the company’s cell engineering technology to develop five drug candidates.

Vor has signed a licensing agreement to access MaxCyte's Flow Electroporation technology and ExPERT family of instruments.

They will be deployed to deliver gene editing machinery into hematopoietic stem cells to remove biologically redundant proteins that are also expressed on blood cancer cells.

Hematopoietic stem cells create white and red blood cells as well as platelets and are found in bone marrow.

Vor has pioneered a process that creates engineered hematopoietic stem cells. Its lead candidate is VOR 33 for the treatment of acute myeloid leukemia.

No financial details of the licensing agreement were revealed; however, Maxcyte said it will receive development and approval milestones and “sales-based payments in addition to other licensing fees”.

Quick facts: MaxCyte Inc

Price: 356 GBX

AIM:MXCT
Market: AIM
Market Cap: £274.69 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of MaxCyte Inc named herein, including the promotion by the Company of MaxCyte Inc in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Market report: UK lockdown fears sink FTSE into a sea of red

The FTSE is in the red this Monday morning with fears prime minister, Boris Johnson, is reportedly considering a two-week mini-lockdown in England in a bid to stem the spread of the virus. We’ll find out later on this week. As a consequence - British Airways parent company, IAG, (LON:IAG) is...

1 day, 15 hours ago

2 min read